학술논문
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
Document Type
Article
Author
Zhong, Hua; Sun, Shengjie; Chen, Jianhua; Wang, Ziping; Zhao, Yanqiu; Zhang, Guojun; Chen, Gongyan; Zhou, Ming; Zhou, Jianying; Du, Yingying; Wu, Lin; Xu, Zhi; Mei, Xiaodong; Zhang, Weidong; He, Jingdong; Cui, Jiuwei; Zhang, Zhihong; Luo, Hui; Liu, Weiyou; Sun, Meili; Wu, Jingxun; Shen, Yongchun; Zhang, Shucai; Yang, Nong; Wang, Mengzhao; Lu, Junguo; Li, Kai; Yao, Weirong; Sun, Qian; Yue, Hongmei; Wang, Lin; Ye, Sheng; Li, Bin; Zhuang, Xibin; Pan, Yueyin; Zhang, Min; Shu, Yongqian; He, Zhiyong; Pan, Lei; Ling, Yang; Liu, Shengming; Zhang, Qi; Jiao, Shunchang ; Han, Baohui
Source
In The Lancet Respiratory Medicine May 2024 12(5):355-365
Subject
Language
ISSN
2213-2600